These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33958335)

  • 21. A comparative study of mortality differences and associated characteristics among elderly and young adult patients hospitalised with COVID-19 in India.
    Mittal K; Dhar M; Pathania M; Jha D; Saxena V
    BMC Geriatr; 2023 Apr; 23(1):247. PubMed ID: 37098474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Death analysis of COVID-19 patients admitted in dedicated COVID hospital in Mumbai.
    Pawar PN; Chavan SS; Jadhao VF; Adsul BB; Kumbhar MA; Dhikale PT; Gokhale CN; Ingale AR
    J Family Med Prim Care; 2022 Apr; 11(4):1322-1326. PubMed ID: 35516686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rarity of cutaneous findings among asymptomatic to mildly symptomatic patients with COVID-19 admitted to a COVID care facility in Delhi, India: an observational study.
    Khurana A; Mittal A; Jain R; Mishra A; Mathachan SR
    Br J Dermatol; 2021 Sep; 185(3):666-667. PubMed ID: 33997962
    [No Abstract]   [Full Text] [Related]  

  • 24. The impact of Covid-19 in Chhattisgarh, India: A descriptive study.
    Agrawal S; Galhotra A; Gahwai D; Dayama S
    J Family Med Prim Care; 2024 Jan; 13(1):221-229. PubMed ID: 38482304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis of mortality and survival of COVID 19 patients admitted to a tertiary care hospital in Maharashtra, India.
    Bobdey S; Chawla N; Behera V; Ray S; Ilankumaran M; Koshy G; Kaushik SK
    Med J Armed Forces India; 2021 Jul; 77(Suppl 2):S353-S358. PubMed ID: 34334904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is cancer significant comorbid condition in COVID 19 infected patients? -A retrospective analysis experienced in a tertiary care center in Eastern India.
    Mukherjee KK; Dam A; Chakrabarti D; Jatu D; Sengupta S; Dutta R; Majumdar S; Mandal SS; Basu B; Bhattacharjee P; Mukherjee D; Sengupta S; Chakrabarti J
    Ann Med Surg (Lond); 2022 Sep; 81():104248. PubMed ID: 35937633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covid-19: Aspirin does not improve survival for patients admitted to hospital, trial reports.
    Iacobucci G
    BMJ; 2021 Jun; 373():n1475. PubMed ID: 34103299
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
    Prats-Uribe A; Sena AG; Lai LYH; Ahmed WU; Alghoul H; Alser O; Alshammari TM; Areia C; Carter W; Casajust P; Dawoud D; Golozar A; Jonnagaddala J; Mehta PP; Gong M; Morales DR; Nyberg F; Posada JD; Recalde M; Roel E; Shah K; Shah NH; Schilling LM; Subbian V; Vizcaya D; Zhang L; Zhang Y; Zhu H; Liu L; Cho J; Lynch KE; Matheny ME; You SC; Rijnbeek PR; Hripcsak G; Lane JC; Burn E; Reich C; Suchard MA; Duarte-Salles T; Kostka K; Ryan PB; Prieto-Alhambra D
    BMJ; 2021 May; 373():n1038. PubMed ID: 33975825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile and outcomes of hospitalized patients with COVID-19 at a tertiary institution hospital in Ghana.
    Ayisi-Boateng NK; Owusu M; Tawiah P; Ampah BA; Sylverken AA; Wusu-Ansah OK; Sarfo FS; Phillips RO
    Ghana Med J; 2020 Dec; 54(4 Suppl):39-45. PubMed ID: 33976440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends Over Time in the Risk of Adverse Outcomes Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Ioannou GN; O'Hare AM; Berry K; Fan VS; Crothers K; Eastment MC; Locke E; Green P; Shah JA; Dominitz JA
    Clin Infect Dis; 2022 Feb; 74(3):416-426. PubMed ID: 33973000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Available medications used as potential therapeutics for COVID-19: What are the known safety profiles in pregnancy.
    Bérard A; Sheehy O; Zhao JP; Vinet E; Quach C; Kassai B; Bernatsky S
    PLoS One; 2021; 16(5):e0251746. PubMed ID: 34010282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary findings from stimulated spontaneous reporting of adverse drug reactions during COVID-19 pandemic: an experience from Ghana.
    Darko DA; Seaneke SK; Sabblah GT; Ashie A; Asamoa-Amoakohene A; Ewudzie JS; Asa-Eck T; Agyei-Kwame E; Dwamena F; Mensah J; Boateng J
    Ghana Med J; 2020 Dec; 54(4 Suppl):62-70. PubMed ID: 33976443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Azithromycin for the Treatment of COVID-19: A Systematic Review and Meta-analysis.
    Mangkuliguna G; Glenardi ; Natalia ; Pramono LA
    Tuberc Respir Dis (Seoul); 2021 Oct; 84(4):299-316. PubMed ID: 34015868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection.
    Khezri MR; Zolbanin NM; Ghasemnejad-Berenji M; Jafari R
    Eur J Pharmacol; 2021 Aug; 905():174191. PubMed ID: 34015317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case.
    Montnach J; Baró I; Charpentier F; De Waard M; Loussouarn G
    Europace; 2021 Jul; 23(7):1124-1133. PubMed ID: 34009333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic postoperative antibiotics after emergent cesarean delivery and risk of postpartum infection or wound complication.
    Dellapiana G; Levian C; Gubernick L; Burwick RM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6830-6835. PubMed ID: 34008468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs].
    Esmel-Vilomara R; Dolader P; Sabaté-Rotes A; Soriano-Arandes A; Gran F; Rosés-Noguer F
    An Pediatr (Barc); 2022 Mar; 96(3):213-220. PubMed ID: 33995537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Report on the Compassionate Use of Baricitinib in Treating a Pediatric Patient With Severe Symptoms of COVID-19 Infection.
    Atemnkeng F; Alataby H; Demirjian J; Kenne FM; Nfonoyim J
    J Med Cases; 2021 Mar; 12(3):94-98. PubMed ID: 33984091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validating and implementing cardiac telemetry for continuous QTc monitoring: A novel approach to increase healthcare personnel safety during the COVID-19 pandemic.
    Kassis N; Tanaka-Esposito C; Chung R; Kalra A; Shao M; Kumar A; Alzubi J; Chung MK; Khot UN
    J Electrocardiol; 2021; 67():1-6. PubMed ID: 33975077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives.
    Al-Kuraishy HM; Al-Gareeb AI; Alqarni M; Cruz-Martins N; El-Saber Batiha G
    Front Pharmacol; 2021; 12():642822. PubMed ID: 33967777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.